Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
294.50 CHF | -1.11% |
|
+1.90% | +15.26% |
Feb. 13 | Roche Elecsys sFlt-1/PlGF Ratio for Preeclampsia Receives FDA 510(K) Clearance | CI |
Feb. 13 | Roche: the stock stands out after an upgrade by UBS | CF |
End-of-day quotes
Sector Other Pharmaceuticals
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
264B | ||||||
760B | ||||||
376B | ||||||
349B | ||||||
340B | ||||||
229B |
- Stock Market
- Equities
- ROG Stock
- Charts Roche Holding AG
- Sector Chart